EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Drug-Coated Balloon in Primary Percutaneous Coronary Intervention

Hui Zhao iD, Runran Miao iD, Fei Lin iD, Guoan Zhao iD

Journal of Interventional Cardiology · 2023

DOI: 10.1155/2023/5210808 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Interventional Cardiology, 2023. Verfasst von Hui Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453100, China. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Coronary, Drug-Eluting Stents, Coronary Restenosis, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Scientific Research Projects of Higher Education Institutions in Henan Province, Henan Provincial Science and Technology Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

According to the latest coronary interventional guidelines, a drug-eluting stent is the recommended reperfusion therapy in primary percutaneous coronary intervention (pPCI). However, deficiencies and defects, such as in-stent restenosis (ISR), incomplete stent apposition, stent thrombosis, reinfarction after stent implantation, long-term dual antiplatelet drug use, and adverse reactions of metal implants, plague clinicians and patients. Drug-coated balloon (DCB), which delivers antiproliferative agents into the vessel wall without stent implantation and leaves no implants behind after the procedure, is a novel option for percutaneous coronary intervention and has proven to be a promising strategy in cases of ISR, small vessel coronary artery disease, and bifurcation lesions. However, most of the available experience has been gained in elective percutaneous coronary intervention, and experience in pPCI is lacking. The current evidence for the use of DCB-only in pPCI was discussed and analyzed in this review.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioplasty, Balloon, CoronaryDrug-Eluting StentsCoronary RestenosisPercutaneous Coronary InterventionCoronary Artery DiseaseHumansTreatment OutcomeCoated Materials, BiocompatibleCoronary Angiography

Substanzen

Coated Materials, Biocompatible

Autor:innen und Institutionen

  • First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453100, China.

ORCID-Profile: Hui Zhao, Runran Miao, Fei Lin, Guoan Zhao

Förderung

  • Key Scientific Research Projects of Higher Education Institutions in Henan Province
  • Henan Provincial Science and Technology Research Project

Zitieren

APA

Zhao, H., Miao, R., Lin, F., & Zhao, G. (2023). Drug-Coated Balloon in Primary Percutaneous Coronary Intervention. Journal of Interventional Cardiology. https://doi.org/10.1155/2023/5210808

Vancouver

Zhao H, Miao R, Lin F, Zhao G. Drug-Coated Balloon in Primary Percutaneous Coronary Intervention. Journal of Interventional Cardiology. 2023. doi:10.1155/2023/5210808

BibTeX
@article{Zhao2023,
  author = {Zhao, Hui and Miao, Runran and Lin, Fei and Zhao, Guoan},
  title = {Drug-Coated Balloon in Primary Percutaneous Coronary Intervention},
  journal = {Journal of Interventional Cardiology},
  year = {2023},
  doi = {10.1155/2023/5210808}
}
Kostenlos starten →